Possible prognostic factor | OR | 95% CI | P-value |
---|---|---|---|
Age (< 64 yr. vs ≥ 64 yr)b | 0.838 | 0.337–2.086 | 0.705 |
p-T stage (T1 vs T2–3) | 0.569 | 0.188–1.721 | 0.318 |
p-TNM stage (I vs II) | 0.642 | 0.258–1.602 | 0.342 |
TLN (< 23 vs ≥ 23)b | 1.956 | 0.766–4.997 | 0.161 |
Sex (male vs female) | 6.193 | 0.826–46.428 | 0.076 |
Tumor location (UT vs MT/LT + EGJ) | 3.809 | 1.353–10.719 | 0.011* |
Lymphovascular invasion (+ vs -) | 7.471 | 2.428–22.990 | < 0.001* |
Perineural invasion (+ vs -) | 2.365 | 0.848–6.591 | 0.100 |
CEA (≥ 5 μg/ml vs < 5 μg/ml)a | 5.545 | 1.787–17.203 | 0.003* |
Tumor grade (poor vs well + moderate) | 3.577 | 1.335–9.581 | 0.011* |
SCC (≥1.5 μg/ml vs < 1.5 μg/ml) a | 0.383 | 0.088–1.659 | 0.199 |
Surgical approach (left vs right) | 0.581 | 0.226–1.499 | 0.262 |
Smoking history (yes vs no) | 0.935 | 0.375–2.329 | 0.886 |
Postoperative complications (yes vs no) | 1.145 | 0.435–3.015 | 0.784 |
BMI (< 23 vs ≥ 23)b | 1.004 | 0.404–2.497 | 0.993 |
Operation time (< 445 min vs ≥ 445 min)b | 0.951 | 0.377–2.397 | 0.915 |
Blood loss (< 200 ml vs ≥ 200 ml)b | 0.493 | 0.143–1.699 | 0.262 |
Tumor size (< 3.0 cm vs ≥ 3.0 cm)b | 0.445 | 0.169–1.173 | 0.101 |